{"id":"https://openalex.org/W1996109234","doi":"https://doi.org/10.1046/j.1360-0443.1997.9267178.x","title":"Assessment of cocaine use with quantitative urinalysis and estimation of new uses","display_name":"Assessment of cocaine use with quantitative urinalysis and estimation of new uses","publication_year":1997,"publication_date":"1997-06-01","ids":{"openalex":"https://openalex.org/W1996109234","doi":"https://doi.org/10.1046/j.1360-0443.1997.9267178.x","mag":"1996109234","pmid":"https://pubmed.ncbi.nlm.nih.gov/9246799"},"language":"en","primary_location":{"id":"doi:10.1046/j.1360-0443.1997.9267178.x","doi":"https://doi.org/10.1046/j.1360-0443.1997.9267178.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1360-0443.1997.9267178.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060972692","display_name":"Kenzie L. Preston","orcid":"https://orcid.org/0000-0003-0603-2479","observed_orcids":["https://orcid.org/0000-0003-0603-2479"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenzie L. Preston","raw_affiliation_strings":["National Institute on Drug Abuse Intramural Research Program, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse Intramural Research Program, Baltimore, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085729704","display_name":"Kenneth Silverman","orcid":"https://orcid.org/0000-0003-2724-1413","observed_orcids":["https://orcid.org/0000-0003-2724-1413"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Silverman","raw_affiliation_strings":["National Institute on Drug Abuse Intramural Research Program, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse Intramural Research Program, Baltimore, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086951861","display_name":"Charles Roberts Schuster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles R. Schuster","raw_affiliation_strings":["National Institute on Drug Abuse Intramural Research Program, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse Intramural Research Program, Baltimore, USA","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110819058","display_name":"Edward J. Cone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward J. Cone","raw_affiliation_strings":["National Institute on Drug Abuse Intramural Research Program, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse Intramural Research Program, Baltimore, USA","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1327069482"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":4.3131,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":{"value":0.92723365,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"92","issue":"6","first_page":"717","last_page":"727"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.885699987411499,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.1031000018119812,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12842","display_name":"Youth, Drugs, and Violence","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/3317","display_name":"Demography"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-use","display_name":"cocaine use","score":0.8349999785423279},{"id":"https://openalex.org/keywords/benzoylecgonine","display_name":"benzoylecgonine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cocaine-metabolites","display_name":"cocaine metabolites","score":0.7789999842643738},{"id":"https://openalex.org/keywords/treatment-outcome-monitoring","display_name":"treatment outcome monitoring","score":0.7630000114440918},{"id":"https://openalex.org/keywords/drug-use-frequency","display_name":"drug use frequency","score":0.6349999904632568},{"id":"https://openalex.org/keywords/self-reported-drug-use","display_name":"self-reported drug use","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C2779225474","wikidata":"https://www.wikidata.org/wiki/Q842424","display_name":"Urinalysis","level":3,"score":0.9745322465896606},{"id":"https://openalex.org/C2777537440","wikidata":"https://www.wikidata.org/wiki/Q2499888","display_name":"Benzoylecgonine","level":3,"score":0.8951466083526611},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5319896936416626},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.49332156777381897},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.49227896332740784},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4729834794998169},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3272373378276825},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29846781492233276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2269848883152008}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015813","descriptor_name":"Substance Abuse Detection","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1046/j.1360-0443.1997.9267178.x","doi":"https://doi.org/10.1046/j.1360-0443.1997.9267178.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1360-0443.1997.9267178.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"doi:10.1111/j.1360-0443.1997.tb02938.x","doi":"https://doi.org/10.1111/j.1360-0443.1997.tb02938.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.1997.tb02938.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"pmid:9246799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9246799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction (Abingdon, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W77037042","https://openalex.org/W1979811416","https://openalex.org/W1981002941","https://openalex.org/W1983159901","https://openalex.org/W1983711991","https://openalex.org/W2069202436","https://openalex.org/W2074854277","https://openalex.org/W2118760227","https://openalex.org/W2161541522","https://openalex.org/W2166925048","https://openalex.org/W2288337919","https://openalex.org/W2412584758"],"related_works":["https://openalex.org/W908966","https://openalex.org/W2043834447","https://openalex.org/W2166135138","https://openalex.org/W2753158570","https://openalex.org/W2401697463","https://openalex.org/W1975373996","https://openalex.org/W2047186973","https://openalex.org/W2166632820","https://openalex.org/W4298744829","https://openalex.org/W1781459936"],"abstract_inverted_index":{"Qualitative":[0],"urinalysis":[1,24,111,143,159,172,195],"methods":[2],"of":[3,10,16,39,89,136,155,170,199],"monitoring":[4,184],"cocaine":[5,32,40,47,58,68,91,98,123,127,200],"use":[6,33,108,156],"may":[7,188],"over-detect":[8],"frequency":[9,154,198],"use,":[11],"possibly":[12],"decreasing":[13],"the":[14,67,101,115,126,139,161,166],"ability":[15],"clinical":[17,116,140,167],"trials":[18],"to":[19,83,86,96,105,178],"detect":[20],"effective":[21],"treatments.":[22],"Quantitative":[23],"and":[25,56,73,104,109,144,153,187],"newly":[26],"developed":[27],"criteria":[28,77,120],"for":[29,66,112,183],"identifying":[30],"new":[31,90],"were":[34,64,81,94],"evaluated":[35],"as":[36],"alternative":[37],"measures":[38],"use.":[41,92,201],"Urine":[42],"specimens":[43],"collected":[44],"in":[45,50,100,114,125,130,160,165,196],"a":[46,57,133,180],"dosing":[48,128],"study":[49,103,129],"non-treatment-seeking":[51],"subjects":[52,113],"(n":[53,61],"=":[54,62],"5)":[55],"treatment":[59,163,185],"trial":[60],"37)":[63],"analyzed":[65],"metabolite,":[69],"benzoylecgonine,":[70],"with":[71,173],"qualitative":[72,110,158,194],"quantitative":[74,84,142,171],"methods.":[75],"Pharmacokinetic":[76],"('New":[78],"Use'":[79],"rules)":[80],"applied":[82],"data":[85],"identify":[87],"occasions":[88],"Results":[93],"compared":[95],"known":[97],"administrations":[99,124],"laboratory":[102],"self-reported":[106],"drug":[107],"trial.":[117,168],"New":[118,146,174],"Use":[119,175],"correctly":[121],"identified":[122],"all":[131],"but":[132],"small":[134],"number":[135],"specimens.":[137],"In":[138],"trial,":[141],"estimated":[145],"Uses":[147],"provided":[148],"more":[149,190],"information":[150],"about":[151],"patterns":[152],"than":[157,192],"different":[162],"conditions":[164],"Interpretation":[169],"rules":[176],"appears":[177],"be":[179,189],"useful":[181],"method":[182],"outcome":[186],"accurate":[191],"traditional":[193],"estimating":[197]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}